Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for Advanced HER2- GC/GEJC - Outcomes in the Protocol-Specified PD-L1-Selected Populations"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Sun Young Rha
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Sun Young Rha
Login to view comments.
Click here to Login